Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, claims Roots Analysis

Pharmaceuticals

The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity

Submitted by Roots_Analysis on 2020-10-16 12:23.

The “Encapsulated Cell Therapies and Encapsulation Technologies Market” report features an extensive study of the current market landscape and future potential, offering an informed opinion on the likely adoption of these therapies / technologies over the

Pharmaceuticals

To order this 500+ page report, please visit this link

Key Inclusions

Submitted by Roots_Analysis on 2020-10-16 12:22.

More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated across different phases of development by stakeholders across the globe, claims Roots Analysis

Pharmaceuticals

Extensive research on cell encapsulation strategies has enabled the development of a variety of technologies capable of immobilizing / enclosing therapeutic entities within biocompatible matrices / carriers. Such products offer a myriad of advantages, and have demonstrated the capability to ... Read more

Submitted by Roots_Analysis on 2020-10-16 12:22.

Given the increasing number of licensing deals and the expected approval of multiple mid-late stage candidates, the encapsulated cell therapies and encapsulation technologies market is anticipated to evolve at a rapid pace over the next decade, predicts R

Pharmaceuticals

Roots Analysis has done a detailed study on Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030 ... Read more

Submitted by Roots_Analysis on 2020-10-16 12:21.

The “Cell Therapy Manufacturing Market (3rd Edition), 2019-2030

Market-Research

Key Inclusions

A detailed review of the overall landscape of companies that are engaged in the manufacturing of cell-based therapies, including information on the type of cells manufactured (including immune cells (including T cells, dendritic cells, NK cells),

Submitted by Roots_Analysis on 2020-10-16 11:29.

More than 100 industry players and over 60 non-industry players currently claim to manufacture

Market-Research

Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key ... Read more

Submitted by Roots_Analysis on 2020-10-16 11:28.

The cell therapy manufacturing market is projected to grow at an annualized rate of >16.5%, till 2030

Market-Research

Roots Analysis has done a detailed study on Cell Therapy Manufacturing Market (3^rd Edition), 2019 - 2030, covering ... Read more

Submitted by Roots_Analysis on 2020-10-16 11:26.

The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030

Market-Research

Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise, they are also becoming increasingly reliant on contract service providers

Submitted by Roots_Analysis on 2020-10-16 11:24.

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market

Market-Research

Submitted by Roots_Analysis on 2020-10-16 11:22.

The “Encapsulated Cell Therapies and Encapsulation Technologies Market” report

Market-Research

Key Inclusions

A detailed assessment of the current market landscape of encapsulated cell therapies and affiliated technologies, highlighting various target disease indications, phase of development, encapsulation method, type of cells / API, and route of

Submitted by Roots_Analysis on 2020-10-16 11:19.

More than 45 encapsulated cell therapies and encapsulation technologies are being evaluated

Market-Research

Submitted by Roots_Analysis on 2020-10-16 11:17.

Given the increasing number of licensing deals and the expected approval

Market-Research

Roots Analysis has done a detailed study on Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030 ... Read more

Submitted by Roots_Analysis on 2020-10-16 11:15.

The “Cell and Advanced Therapies Supply Chain Management Market, 2020-2030

Market-Research

Key Inclusions

A detailed assessment of the current market landscape, featuring a comprehensive list of over 160 technological platforms that are being used to manage the cell and advanced therapies supply chain, along with

Submitted by Roots_Analysis on 2020-10-15 14:36.

Presently, over 160 innovative, software enabled systems are being used to efficiently

Market-Research

The cell and advanced therapies supply chain is complex, with several legacy challenges, such as those related to patient scheduling, resource planning, inventory management, and deliverable tracking. A number of innovative, software-enabled systems are available / under development to ... Read more

Submitted by Roots_Analysis on 2020-10-15 14:34.

Given the cost saving potential across different processes and operations

Market-Research

Roots Analysis has done a detailed study on Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions (Cell ... Read more

Submitted by Roots_Analysis on 2020-10-15 14:31.

The “Companion Diagnostics Development Services Market, 2020-2030

Market-Research

Key Inclusions

A detailed assessment of the current market landscape of companies offering companion diagnostics services, including information on the type of services offered, type of analytical technique used and regulatory certifications / accreditations, and

Submitted by Roots_Analysis on 2020-10-15 14:28.

Over 180 companies from different regions across the globe presently claim to provide services

Market-Research

It is estimated that around 80% of innovator companies rely on external companion diagnostic developers, mostly owing to the lack of the required in-house expertise. On the other hand, there are numerous contract service providers, offering vast portfolios of services for diagnostic test / assay ... Read more

Submitted by Roots_Analysis on 2020-10-15 14:27.

The Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%,

Market-Research

Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market covering key aspects of the industry and identifying future growth opportunities

To order this 320+ page ... Read more

Submitted by Roots_Analysis on 2020-10-15 14:24.

The Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million in 2030

Market-Research

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise

Submitted by Roots_Analysis on 2020-10-15 14:22.

The “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030

Market-Research

Key Inclusions

A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies, featuring details on immuno-oncology biomarkers and disease indications being investigated, based on trial registration year, phase of

Submitted by Roots_Analysis on 2020-10-14 12:55.

Pages